Rxo annual revenue
2020
2021
2022
2023
2024
2025
Rxo Revenue Growth & History (RXO)
Rxo reported $5.74B in revenue for fiscal 2025, an increase of 26.20% from the previous fiscal year.
View full Rxo company overviewRxo annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $5.74B | $1.19B | +26.20% |
| 2024 | 2024-12-31 | $4.55B | $623.0M | +15.86% |
| 2023 | 2023-12-31 | $3.93B | −$869.0M | −18.12% |
| 2022 | 2022-12-31 | $4.80B | $107.0M | +2.28% |
| 2021 | 2021-12-31 | $4.69B | $1.33B | +39.68% |
| 2020 | 2020-12-31 | $3.36B | — | — |
Rxo quarterly revenue
Q3.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $1.77B | $355.0M | +25.02% |
| Q1 2026 | 2026-03-31 | $1.43B | −$8.0M | −0.56% |
| Q4 2025 | 2025-12-31 | $1.47B | −$198.0M | −11.88% |
| Q3 2025 | 2025-09-30 | $1.42B | $381.0M | +36.63% |
| Q2 2025 | 2025-06-30 | $1.42B | $489.0M | +52.58% |
| Q1 2025 | 2025-03-31 | $1.43B | $520.0M | +56.96% |
| Q4 2024 | 2024-12-31 | $1.67B | $689.0M | +70.45% |
| Q3 2024 | 2024-09-30 | $1.04B | $64.0M | +6.56% |
| Q2 2024 | 2024-06-30 | $930.0M | −$33.0M | −3.43% |
| Q1 2024 | 2024-03-31 | $913.0M | −$97.0M | −9.60% |
| Q4 2023 | 2023-12-31 | $978.0M | −$142.0M | −12.68% |
| Q3 2023 | 2023-09-30 | $976.0M | −$162.0M | −14.24% |
| Q2 2023 | 2023-06-30 | $963.0M | −$263.0M | −21.45% |
| Q1 2023 | 2023-03-31 | $1.01B | −$302.0M | −23.02% |
| Q4 2022 | 2022-12-31 | $1.12B | — | — |
| Q3 2022 | 2022-09-30 | $1.14B | −$60.0M | −5.01% |
| Q2 2022 | 2022-06-30 | $1.23B | — | — |
| Q1 2022 | 2022-03-31 | $1.31B | — | — |
| Q3 2021 | 2021-09-30 | $1.20B | — | — |
Rxo revenue growth trends
Over the last five reported fiscal years, revenue grew from $3.36B to $5.74B, a compound annual growth rate of 11.33%. Rxo's latest reported quarter, Q2 2026, generated $1.77B in revenue, an increase of 25.02% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Rxo source filings ↗